FDA Inspection 1264797 — Chrysoula Doxani, M.D.
The FDA completed an inspection of Chrysoula Doxani, M.D. on Feb 20, 2025 in Larissa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Larissa (Greece)
Additional Details
Clinical BA/BE